Deanna L. Kirkpatrick

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,300,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 1.375% U.S. dollar bonds due 2023 issued by Export Development Canada. Export…

Davis Polk advised the sole underwriter in connection with the initial public offering of 27,600,000 units of CITIC Capital Acquisition Corp., including 3,600,000 units purchased pursuant…

Davis Polk advised the joint book-running managers in connection with the $180 million initial public offering of common stock of Beam Therapeutics Inc. The common stock is listed on the…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $1 billion aggregate principal amount of its floating-rate senior notes due 2023, under its medium-term…

Davis Polk advised the underwriters in connection with the offering of $3 billion aggregate principal amount of 1.750% bonds due January 24, 2023 issued by the Province of Ontario. The…

Davis Polk advised the underwriters in connection with the offering of $3 billion aggregate principal amount of 1.625% U.S. dollar bonds due January 22, 2025, issued by Her Majesty in…

Davis Polk advised LIV Capital Acquisition Corp. on its $70 million initial public offering of 7,000,000 units. Each unit had an initial offering price of $10 and consists of one Class A…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $25 million public offering of 4,166,667 common shares of…

Davis Polk advised the underwriters in connection with the offering of C$750 million aggregate principal amount of 2.65% bonds due February 5, 2025, issued by the Province of Ontario. The…